Y2D

1-[(3R,4R)-3-[4-(pyridin-3-yl)-1H-1,2,3-triazol-1-yl]-4-{[4-(trifluoromethyl)phenyl]methoxy}pyrrolidin-1-yl]prop-2-en-1-one

Created:	2021-01-28
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where Y2D is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	52
Chiral Atom Count	2
Bond Count	55
Aromatic Bond Count	17

2D diagram of Y2D

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	1-[(3R,4R)-3-[4-(pyridin-3-yl)-1H-1,2,3-triazol-1-yl]-4-{[4-(trifluoromethyl)phenyl]methoxy}pyrrolidin-1-yl]prop-2-en-1-one
Synonyms	1-[(3~{R},4~{R})-3-(4-pyridin-3-yl-1,2,3-triazol-1-yl)-4-[[4-(trifluoromethyl)phenyl]methoxy]pyrrolidin-1-yl]prop-2-en-1-one
Systematic Name (OpenEye OEToolkits)	1-[(3~{R},4~{R})-3-(4-pyridin-3-yl-1,2,3-triazol-1-yl)-4-[[4-(trifluoromethyl)phenyl]methoxy]pyrrolidin-1-yl]prop-2-en-1-one
Formula	C₂₂ H₂₀ F₃ N₅ O₂
Molecular Weight	443.422
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	c1cc(C(F)(F)F)ccc1COC2C(CN(C2)C(\C=C)=O)n3cc(nn3)c4cccnc4
SMILES	CACTVS	3.385	FC(F)(F)c1ccc(CO[CH]2CN(C[CH]2n3cc(nn3)c4cccnc4)C(=O)C=C)cc1
SMILES	OpenEye OEToolkits	2.0.7	C=CC(=O)N1CC(C(C1)OCc2ccc(cc2)C(F)(F)F)n3cc(nn3)c4cccnc4
Canonical SMILES	CACTVS	3.385	FC(F)(F)c1ccc(CO[C@@H]2CN(C[C@H]2n3cc(nn3)c4cccnc4)C(=O)C=C)cc1
Canonical SMILES	OpenEye OEToolkits	2.0.7	C=CC(=O)N1C[C@H]([C@@H](C1)OCc2ccc(cc2)C(F)(F)F)n3cc(nn3)c4cccnc4
InChI	InChI	1.03	InChI=1S/C22H20F3N5O2/c1-2-21(31)29-12-19(30-11-18(27-28-30)16-4-3-9-26-10-16)20(13-29)32-14-15-5-7-17(8-6-15)22(23,24)25/h2-11,19-20H,1,12-14H2/t19-,20-/m1/s1
InChIKey	InChI	1.03	AZGCPBIUNCLWPF-WOJBJXKFSA-N

Related Resource References

Resource Name	Reference
PubChem	162623428

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.